Talcum Powder Cancer Lawsuit

Multiple Scientific Inquiries Have Investigated The Presence Of Talc Particles In Cancerous Ovarian Tissues

The evidence linking talc with ovarian cancer is scientifically sound

Sunday, August 20, 2023 - The potential correlation between talcum powder and ovarian cancer has attracted substantial attention within the medical, scientific, and legal communities. More than 38,000 talcum powder lawsuits are waiting to be heard in courtrooms all over the country. Numerous studies have surfaced suggesting a potential association between talc usage in the genital region and an elevated risk of ovarian cancer. A compelling aspect of this research revolves around the discovery of talc particles present within ovarian cancer patients' tissues, fueling debates about the plausibility of a causal link. Multiple scientific inquiries have investigated the presence of talc particles in ovarian tissues, igniting controversy over whether talc could indeed contribute to the onset of ovarian cancer. One such study, published in 2016 in "Cancer Epidemiology, Biomarkers & Prevention," examined the existence of talc particles within tissue samples obtained from ovarian cancer patients. Employing advanced imaging methods, the researchers identified and scrutinized talc particles within the samples. The study's findings indicated the detectability of talc particles within a significant proportion of the examined ovarian tissues, suggesting a possible relationship between talcum powder usage and ovarian cancer. Another noteworthy study, documented in the "European Journal of Cancer Prevention" in 2016, undertook an in-depth exploration of talc particle presence in ovarian tissues and its potential impact on ovarian cancer development. Researchers extensively analyzed talc content in ovarian tissues sourced from both talcum powder ovarian cancer patients and control groups. The study's outcomes revealed a higher incidence of talc particles in the ovarian tissues of women diagnosed with ovarian cancer, lending support to the hypothesis that talc exposure might play a role in initiating or progressing this form of cancer.

On December 10, 2019, Dr. Jacqueline Moline's testified before the Committee on Oversight and Reform Subcommittee on Economic and Consumer Policy in the United States House of Representatives. Her testimony left no doubt that one could not rule out the presence of asbestos in talc and that both talc and asbestos could cause oxidative stress when trapped in the ovaries and potentially lead to cancer. Dr. Moline told Congress, "In addition to mesothelioma, more and more evidence is coming to light to support the proposition that cosmetic talcum powder is causing some women's ovarian cancer as well. The scientific evidence is clear that asbestos causes ovarian cancer. Recent studies that have looked at perineal talc exposure and ovarian cancer risk have found elevated cancer risk, particularly for the most common type of ovarian cancer: serous carcinoma of the ovary. The authors of these papers do not differentiate between the risk of talcum powder itself and asbestos as a contaminant of the talcum powder." Dr. Moline is a frequent plaintiff expert witness and has testified against Johnson & Johnson and other manufacturers of talc in court. Johnson & Johnson has filed a lawsuit against Dr. Molina for fraud in an attempt to disparage her research. Dr. Moline is a respected Occupational Medicine Specialist and Professor of Occupational Medicine, Epidemiology and Prevention, and Internal Medicine, as well as a department chair at the Donald & Barbara Zucker School of Medicine at Hofstra/Northwell. She is also Director of the Northwell Health Queens World Trade Center Health Program and Director of the New York State-funded Occupational and Environmental Medicine of Long Island Clinical Center, according to DrugWatch.com.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.